Related Experiment Videos
[Prevention of cardiovascular diseases by intervention in lipid metabolism]
Insights
High LDL-cholesterol contributes to arterial plaque buildup, but individual responses vary significantly. Tailoring prevention and treatment strategies for coronary heart disease is crucial due to this biological variation.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Atherosclerosis Research
Context:
- Atherogenesis is a complex process influenced by multiple factors.
- Elevated low-density lipoprotein cholesterol (LDL-C) is a primary driver of cholesterol deposition in arterial walls.
- Significant biological variation exists in how individuals' arterial walls respond to hypercholesterolemia.
Purpose:
- To highlight the critical role of LDL-cholesterol in atherogenesis.
- To underscore the variability in individual responses to high LDL-C levels.
- To emphasize the need for differentiated strategies in cardiovascular disease prevention and treatment.
Summary:
- Experimental, clinical, and epidemiological studies confirm LDL-C's major role in atherogenesis.
- Despite this, some individuals tolerate severe hypercholesterolemia without developing premature coronary heart disease.
- This variability necessitates distinct approaches for primary and secondary prevention, as well as population versus individual therapeutic strategies.
Impact:
- Current knowledge strongly supports the role of lipids and lipoproteins in atherogenesis.
- Epidemiological and intervention studies validate the benefits of lipid-lowering therapies.
- Understanding individual variability can optimize cardiovascular disease management and prevention efforts.
Abstract:
Atherogenesis is a multifactorial event. Experimental, clinical and epidemiological studies, however, have clearly indicated the major role of LDL-cholesterol in the process of cholesterol deposition in the arterial wall. Although most patients with severe hypercholesterolemia suffer from premature coronary heart disease, it is a medical experience, that there are subjects who tolerate hypercholesterolemia and reach high ages without problems of their coronary arteries. Thus, there is much biological variation in the response of the arterial wall to elevated LDL-cholesterol, a fact which emphasizes the need to differentiate between goals and means of primary and the goals and means of secondary prevention of coronary heart disease and between the goals of a population strategy and the goals and means of an individual therapeutic strategy. Today the knowledge about the role of lipids and lipoproteins in atherogenesis is convincing. Epidemiological as well as intervention studies have proven the benefit of an appropriate lipid lowering therapy.